Strata Critical Medical, Inc. (SRTA) financial statements and ratios from SEC XBRL: revenue $0.2B (TTM), net margin 21.0%, revenue growth 2.4% YoY, P/E 13.3. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $197.14M |
| Revenue (TTM) | $0.2B |
| Net Margin | 21.0% |
| Operating Margin (TTM) | -8.6% |
| Revenue Growth (YoY) | 2.4% |
| EPS Growth (YoY) | 140.0% |
| FCF Growth (YoY) | -228.0% |
| P/E Ratio | 13.3 |
| Price / Book | 1.92 |
| Price / Sales | 2.53 |
| FCF Yield | -9.7% |
| Altman Z-Score | 7.11 (safe) |
| Industry P/E (Healthcare Services) | 25.4 |
| Sector P/E (Healthcare) | 21.9 |
SRTA overview · SRTA earnings · SRTA KPIs · SRTA documents · SRTA ownership · SRTA peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.